To order this 320+ page report, which features 120+ figures and 115+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html

Key Market Insights
 Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests
 Currently, a variety of services are available across the entire diagnostics development supply chain, including assays based on a wide range of analytical techniques, especially in the developed geographies
 Numerous pharmaceutical players are actively seeking to enter into partnership with companion diagnostics service providers, in order to leverage the latter’s expertise in this field
 The rise in interest in this field is reflected in the number of partnerships established in the recent past, involving both international and indigenous stakeholders, and focused on a variety of end objectives
 In order to achieve an edge over the contemporary competition, companies engaged in this domain are increasingly focusing on the integration of advanced service offerings in their respective portfolios
 The value chain involves drug and diagnostics developers, service providers, along with other important stakeholders, each having a discrete set of priorities and requirements
 Given the growing demand for precision medicine, the companion diagnostics services market is expected to witness a double digit growth; the opportunity is likely to be distributed across different regions and techniques
 In the long-term, growth in the market is anticipated to be driven by the clinical studies based on novel tumor markers, which have been identified as promising biological targets for development of companion diagnostics

For more information, please visit https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]